Cathay Biotech projects profit down over 30% in 2023

Summary: Cathay Biotech forecasted 13.39% and 35.32% drops in revenue and total profit in 2023, with increased R&D funds in bio-based products; its 500,000 t/a bio-based PDA and 900,000 t/a bio-based PA project is delayed for startup to 31 Dec., 2025...

Bio-based Material Quarterly Newsletter Q1 2024

www.cnchemicals.com